RT Journal Article
SR Electronic
T1 Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma: A Case Report
JF Cancer Biology and Medicine
JO Cancer Biol Med
FD China Anti-Cancer Association
SP 133
OP 136
DO 10.3969/j.issn.2095-3941.2012.02.010
VO 9
IS 2
A1 Gaur, Sumit
A1 Torabi, Alireza
A1 O’Neill, Thomas J
YR 2012
UL http://www.cancerbiomed.org/content/9/2/133.abstract
AB This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound paclitaxel. The treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid hemangioendothelioma. Literature describing the activity of bevacizumab and other agents (thalidomide, lenalidomide, and interferon) believed to possess anti-angiogenic activities is also reviewed.